sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device Europe Wearable Injectors Market...

Europe Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (On-Body Injectors, Off-Body Injectors); Application (Diabetes, Oncology, Cardiovascular Disease, Autoimmune Disease, Other Applications); End User (Hospitals and Clinics, Homecare Setting, Other End User), and Country

TIPRE00013296 | Pages: 117 | Medical Device | Aug 2020 | Type: Regional | Status: Published

Market Introduction

This research report provides insights into the global wearable injectors market. Wearable injectors (WI) are drug delivery devices adhere to the body to deliver larger volumes of drug subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. WIs consists of reservoir for the medication, a cannula for delivery to the tissue, adhesive to fix the device to the patient’s skin, and a drive system to deliver the appropriate drug volume.

The scope of the wearable injectors market includes type, application, end user and region. The market for wearable injector is analyzed based on Europe region. The report offers insights and in-depth analysis of the wearable injectors market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.


Get more information on this report :



Market Overview and Dynamics

The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system limitations. However, the market is likely to have negative impact due to preference of alternative drug delivery

Key Market Segments

Based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors. The on-body injectors segment held the largest share of the market in 2019. However, the off-body injectors segment is estimated to register the highest CAGR of 11.9% in the market during the forecast period.

Based on application, the market is segmented into oncology, diabetes, autoimmune diseases, cardiovascular disease and other applications. The oncology segment held the largest share of the market in 2019. However, the autoimmune disease segment is estimated to register the highest CAGR of 12.2% in the market during the forecast period.

Based on end user, the market is segmented into homecare settings, hospital and clinical and other end users. The homecare setting segment held the largest share of the market in 2019. However, the hospitals and clinics segment is estimated to register the highest CAGR of 11.8% in the market during the forecast period.

Major Sources and Companies Listed

Some of the major primary and secondary sources for Europewearable injectors market included in the report are European Council of Medical Research, Ministry of Health and Family Welfare, World Health Organization, European Journal of Cancer (EJC),International Diabetes Federation (IDF),European Society of Cardiology,and others.

Reasons to buy the report

  • To understand the Europewearable injectors market landscape and identifymarket segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europewearable injectors market
  • Efficiently plan M&A and partnership dealsin Europewearable injectors market by identifying market segments with the most promising probable sales
  • Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europewearable injectors market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe.

 

Europe Wound Irrigation Solutions Market –

By Type

·         On-body Injectors

·         Off-body Injectors

By Application

·         Diabetes

·         Oncology

·         Cardiovascular Disease

·         Autoimmune Disease

·         Other Applications

By End User

·         Hospitals and Clinics

·         Homecare Setting

·         Other End User

By Country

·      Germany

·      UK

·      Russia

·      France

·      Italy

·      Spain

·      Poland

·      Netherlands

·      Austria

·      Switzerland

 

Company Profiles

  • Amgen, Inc.
  • Medtronic
  • BD
  • CeQur SA
  • Debiotech S.A
  • E3D Elcam Drug Delivery Devices
  • Insulet Corporation
  • Gerresheimer AG
  • Tandem Diabetes Care Inc
  • Zealand Pharma A/S
  • West Pharmaceutical Services, Inc
  • Ypsomed AG
  • Medtronic
  • Amgen, Inc

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Global Wearable Injectors Market – By Type

1.3.2        Global Wearable Injectors Market – By Application

1.3.3        Global Wearable Injectors Market – By End User

1.3.4        Global Wearable Injectors Market – By Geography

2.           Europe Wearable Injectors Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Wearable Injectors Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Wearable Injectors Market - Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Wearable Injectors Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Chronic Diseases Prevalence

5.1.2        Technological Advancements and Design Development

5.1.3        Conventional Drug Delivery System Limitations

5.2         Market Restraints

5.2.1        Preference Of Alternative Drug Delivery

5.3         Market Opportunities

5.3.1        Increasing Demand for Biologics

5.4         Future Trends

5.4.1        Integration of Wearable Injectors During Early Drug Development

5.5         Impact Analysis

6.           Wearable Injectors Market – Europe Analysis

6.1         Europe Wearable Injectors Market Revenue Forecasts and Analysis

7.         Europe Wearable Injectors Market Analysis And Forecasts To 2027 – By Type

7.1         Overview

7.2         Europe Wearable Injectors market, By Type 20110 & 2027 (%)

7.2.1        Europe Wearable Injectors Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.3         On-Body Injectors

7.3.1        Overview

7.3.2        Europe On-Body Injectors Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Off-Body Injectors

7.4.1        Overview         

7.4.2        Europe Off-Body Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

Europe Wearable Injectors Market Analysis –  By Application

8.1         Overview

8.2         Europe Wearable Injectors Market, By Application 20110-2027 (%)

8.2.1        Europe Wearable Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Diabetes

8.3.1        Overview

8.3.2        Europe Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Oncology

8.4.1        Overview

8.4.2        Europe Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Cardiovascular Disease

8.5.1        Overview

8.5.2        Europe Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Autoimmune Disease

8.6.1        Overview

8.6.2        Europe Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Other Applications

8.7.1        Overview

8.7.2        Europe Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Europe Wearable Injectors Market Analysis –  By End User

9.1         Overview

9.2         Europe Wearable Injectors Market, By End User 2019-2027 (%)

9.2.1        Europe Wearable Injectors Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Europe Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

9.4         Homecare Setting

9.4.1        Overview

9.4.2        Europe Homecare Setting Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Other End User

9.5.1        Overview

9.5.2        Europe Other End User Market Revenue and Forecasts to 2027 (US$ Mn)

 

10.        Wearable Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1      Europe Wearable Injectors Market Revenue and Forecasts To 2027...........................

10.2.1     Overview

10.2.2     Europe: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)

10.2.3     Europe Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.4     Europe Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.5     Europe Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.6     Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)

10.2.7     Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1       Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2       Germany Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.3       Germany Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.7.4       Germany Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.8     UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1       UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2       UK Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.3       UK Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.8.4       UK Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.9     France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1       France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2       France Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.3       France Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.9.4       France Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.10  Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1    Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2    Spain Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.3    Spain Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.10.4    Spain Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.11  Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1    Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2    Italy Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.3    Italy Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.11.4    Italy Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Europe Wearable Injectors Market

11.1      Europe: Impact Assessment of COVID-19 Pandemic

12.        Wearable Injectors Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market, (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      BD

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      CeQur SA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Debiotech S.A.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      E3D Elcam Drug Delivery Devices

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Insulet Corporation

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Gerresheimer AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Tandem Diabetes Care Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Zealand Pharma A/S

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      West Pharmaceutical Services, Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Ypsomed AG

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Medtronic

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

13.13   Amgen, Inc.

13.13.1  Key Facts

13.13.2  Business Description

13.13.3  Products and Services

13.13.4  Financial Overview

13.13.5  SWOT Analysis

13.13.6  Key Developments                                      

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             Europe Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 3.             Europe Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             Germany Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 6.             Germany Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             UK Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             UK Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 9.             UK Wearable Injectors Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 10.          France Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          France Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 12.          France Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 15.          Spain Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Italy Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Italy Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 18.          Italy Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          List of Abbreviation                                                                

LIST OF FIGURES

Figure 1.           Wearable Injectors Market Segmentation

Figure 2.           Europe Wearable Injectors Market Overview

Figure 3.          Europe: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 4.          Europe Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 5.          Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)

Figure 6.          Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 7.          UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 8.          France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 9.          Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 10.        Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 11.         Impact of Covid-19 Pandemic In North American Country Markets

 

  1. BD
  2. CeQur SA
  3. Debiotech S.A
  4. E3D Elcam Drug Delivery Devices
  5. Insulet Corporation
  6. Gerresheimer AG
  7. Tandem Diabetes Care Inc
  8. Zealand Pharma A/S
  9. West Pharmaceutical Services, Inc
  10. Ypsomed AG
  11. Medtronic
  12. Amgen, Inc
  • To understand the Europewearable injectors market landscape and identify market segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europewearable injectors market.
  • Efficiently plan M&A and partnership deals in Europe wearable injectors market by identifying market segments with the most promising probable sales.
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europewearable injectors market.
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1500
Site License
$4000
$2000
Enterprise License
$5000
$2500
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription